NCT04952506View on ClinicalTrials.gov

Clinical Study to Compare the Pharmacokinetics and Safety of D113 With CKD-349 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

July 19, 2021

Primary Completion Date

July 29, 2021

Study Completion Date

August 20, 2021

Conditions
Chronic Renal Failure
Interventions
DRUG

CKD-349 F1 Tab.

1T Single does

DRUG

CKD-349 F2 Tab.

1T Single does

DRUG

D113 Tab.

1T Single does

Trial Locations (1)

Unknown

Chungnam National University Hospital, Daejeon

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY